211 related articles for article (PubMed ID: 19588483)
21. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling.
Wang Z; Luo F; Li L; Yang L; Hu D; Ma X; Lu Z; Sun L; Cao Y
Eur J Cancer; 2010 Nov; 46(16):2996-3006. PubMed ID: 20709526
[TBL] [Abstract][Full Text] [Related]
22. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells.
Lui VW; Yau DM; Wong EY; Ng YK; Lau CP; Ho Y; Chan JP; Hong B; Ho K; Cheung CS; Tsang CM; Tsao SW; Chan AT
Carcinogenesis; 2009 Dec; 30(12):2085-94. PubMed ID: 19843642
[TBL] [Abstract][Full Text] [Related]
23. Role of the RARRES1 gene in nasopharyngeal carcinoma.
Kwok WK; Pang JC; Lo KW; Ng HK
Cancer Genet Cytogenet; 2009 Oct; 194(1):58-64. PubMed ID: 19737656
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
25. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
26. EB virus promotes metastatic potential by boosting STIM1-dependent Ca
Wei J; Ye J; Luo Y; Weng J; He Q; Liu F; Li M; Lin Y; Li Y; Zhang Z; Qu S; Zhang J
Cancer Lett; 2020 May; 478():122-132. PubMed ID: 32165272
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
28. STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma.
Ho Y; Tsao SW; Zeng M; Lui VW
Cancer Lett; 2013 Apr; 330(2):141-9. PubMed ID: 23220625
[TBL] [Abstract][Full Text] [Related]
29. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
30. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
31. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.
Burgos JS
Med Oncol; 2005; 22(2):113-21. PubMed ID: 15965273
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB.
Chang MS; Kim DH; Roh JK; Middeldorp JM; Kim YS; Kim S; Han S; Kim CW; Lee BL; Kim WH; Woo JH
J Virol; 2013 Oct; 87(19):10515-23. PubMed ID: 23824821
[TBL] [Abstract][Full Text] [Related]
34. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
35. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
[TBL] [Abstract][Full Text] [Related]
36. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
37. Relationship between Epstein-Barr virus infection and nasopharyngeal carcinoma pathogenesis.
Lin CT
Ai Zheng; 2009 Aug; 28(8):791-804. PubMed ID: 19664324
[TBL] [Abstract][Full Text] [Related]
38. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
39. Association of Epstein-Barr virus with tumor cell proliferation: clinical implication in nasopharyngeal carcinoma.
Kijima T; Kinukawa N; Gooding WE; Uno M
Int J Oncol; 2001 Mar; 18(3):479-85. PubMed ID: 11179475
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
